These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20520538)

  • 41. Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease.
    Ram CV
    Future Cardiol; 2009 Sep; 5(5):453-65. PubMed ID: 19715410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.
    Minami J; Ohno E; Furukata S; Ishimitsu T; Matsuoka H
    J Hum Hypertens; 2009 Oct; 23(10):683-6. PubMed ID: 19369955
    [No Abstract]   [Full Text] [Related]  

  • 43. Peptides as targets for antihypertensive drug development.
    Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
    J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Management of resistant hypertension. Expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology].
    Denolle T; Chamontin B; Doll G; Fauvel JP; Girerd X; Herpin D; Vaïsse B; Villeneuve F; Halimi JM
    Presse Med; 2014 Dec; 43(12 Pt 1):1325-31. PubMed ID: 25459067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment.
    Ponticelli C; Cucchiari D
    J Nephrol; 2017 Apr; 30(2):155-157. PubMed ID: 28211033
    [No Abstract]   [Full Text] [Related]  

  • 46. [Points at issue in the Japanese Society of Hypertension's Guidelines for the Management of Hypertension (JSH2009)].
    Ishimitsu T
    Nihon Jinzo Gakkai Shi; 2009; 51(4):456-60. PubMed ID: 19601553
    [No Abstract]   [Full Text] [Related]  

  • 47. Unsuccessfully Treated Hypertension: A Major Public Health Problem With a Potential Solution.
    Furberg CD; Sealey JE; Blumenfeld JD
    Am J Hypertens; 2017 Sep; 30(9):857-860. PubMed ID: 28482060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The evolution of combination therapy in treating hypertension.
    Weber MA
    J Clin Hypertens (Greenwich); 2007 Dec; 9(12 Suppl 5):1-4. PubMed ID: 18046106
    [No Abstract]   [Full Text] [Related]  

  • 49. Moderate sodium restriction, angiotensin converting enzyme inhibition, and thiazide diuretic in the management of essential hypertension.
    Singer DR; Markandu ND; Furnival L; Khoshnodi L; MacGregor GA
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S5-7. PubMed ID: 2474103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimal renin-angiotensin system blockade-wishful thinking?
    Makani H; Bangalore S; Messerli FH
    Nat Rev Cardiol; 2013 Aug; 10(8):486. PubMed ID: 23817190
    [No Abstract]   [Full Text] [Related]  

  • 51. Evolution and hypertension: is the Renin system necessary?
    Gavras H; Brunner HR
    Hypertension; 2007 Jun; 49(6):e36; author reply e37. PubMed ID: 17389253
    [No Abstract]   [Full Text] [Related]  

  • 52. A Review of Antihypertensive Medications, Part I.
    Felicilda-Reynaldo RF; Kenneally M
    Medsurg Nurs; 2015; 24(3):177-81, 188. PubMed ID: 26285382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Essential hypertension and natriuretic peptides].
    Kanmatsuse K; Fujita H
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():110-2. PubMed ID: 15506350
    [No Abstract]   [Full Text] [Related]  

  • 54. The role of therapeutic inertia and the use of fixed-dose combination therapy in the management of hypertension.
    Basile J; Black HR; Flack JM; Izzo JL
    J Clin Hypertens (Greenwich); 2007 Aug; 9(8):636-45. PubMed ID: 17673886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resistant hypertension and the neglected antihypertensive: sodium restriction.
    Agarwal R
    Nephrol Dial Transplant; 2012 Nov; 27(11):4041-5. PubMed ID: 22899870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High sodium intake is associated with masked hypertension in Japanese patients with type 2 diabetes and treated hypertension.
    Uzu T; Nakao K; Kume S; Araki H; Isshiki K; Araki S; Kawai H; Ugi S; Kashiwagi A; Maegawa H
    Am J Hypertens; 2012 Nov; 25(11):1170-4. PubMed ID: 22810841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimizing blood pressure control in patients with nondiabetic glomerular disease.
    Umanath K; Lewis JB; Dwyer JP
    Adv Chronic Kidney Dis; 2014 Mar; 21(2):200-4. PubMed ID: 24602469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypertension in Children and Adolescents.
    Samuels JA; Zavala AS; Kinney JM; Bell CS
    Adv Chronic Kidney Dis; 2019 Mar; 26(2):146-150. PubMed ID: 31023449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renin-angiotensin system blockade: time for a reappraisal?
    Ruilope LM
    Eur Heart J; 2014 Jul; 35(26):1703-5. PubMed ID: 24722805
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of systolic hypertension and severe asymptomatic aortic regurgitation.
    Handler J
    J Clin Hypertens (Greenwich); 2008 Dec; 10(12):951-5. PubMed ID: 19120724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.